UK Markets closed

Dillard's, Inc. (DDS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
263.18-4.86 (-1.81%)
As of 12:46PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3416.71
52-week low 3127.05
50-day moving average 3289.09
200-day moving average 3253.14

Share statistics

Avg vol (3-month) 3240.82k
Avg vol (10-day) 3280.7k
Shares outstanding 515.45M
Implied shares outstanding 6N/A
Float 84.21M
% held by insiders 127.85%
% held by institutions 179.50%
Shares short (28 Apr 2022) 41.75M
Short ratio (28 Apr 2022) 49.28
Short % of float (28 Apr 2022) 440.95%
Short % of shares outstanding (28 Apr 2022) 49.60%
Shares short (prior month 30 Mar 2022) 41.91M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.25%
Trailing annual dividend rate 30.65
Trailing annual dividend yield 30.24%
5-year average dividend yield 40.72
Payout ratio 41.67%
Dividend date 301 May 2022
Ex-dividend date 429 Mar 2022
Last split factor 23:1
Last split date 307 Jun 1992

Financial highlights

Fiscal year

Fiscal year ends 28 Jan 2022
Most-recent quarter (mrq)28 Jan 2022

Profitability

Profit margin 13.02%
Operating margin (ttm)16.75%

Management effectiveness

Return on assets (ttm)21.88%
Return on equity (ttm)59.64%

Income statement

Revenue (ttm)6.62B
Revenue per share (ttm)321.69
Quarterly revenue growth (yoy)33.40%
Gross profit (ttm)2.88B
EBITDA 1.31B
Net income avi to common (ttm)862.47M
Diluted EPS (ttm)28.61
Quarterly earnings growth (yoy)379.20%

Balance sheet

Total cash (mrq)716.76M
Total cash per share (mrq)39.03
Total debt (mrq)608.73M
Total debt/equity (mrq)41.95
Current ratio (mrq)1.98
Book value per share (mrq)80.49

Cash flow statement

Operating cash flow (ttm)1.28B
Levered free cash flow (ttm)1.02B